Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tsuneo Takenaka, Mika Okayama, Eriko Kojima, Yuka Nodaira, Jonde Arai, Kosuke Uchida, Tomohiro Kikuta, Keita Sueyoshi, Hitoshi Hoshi, Yusuke Watanabe, Hiroshi Takane & Hiromichi Suzuki. (2013) Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy on Hemodialysis. Clinical and Experimental Hypertension 35:4, pages 244-249.
Read now
Read now
Articles from other publishers (5)
Musab Hommos & Carrie Schinstock. 2017. Hypertension: from basic research to clinical practice. Hypertension: from basic research to clinical practice
327
340
.
Yoshiyuki Morishita, Eiji Kusano & Daisuke Nagata. (2014) Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis. The Open Cardiovascular Medicine Journal 8:1, pages 6-11.
Crossref
Crossref
Walid Arkouche, Philippe Giaime & Lucile Mercadal. (2013) Évaluation et traitement de la surcharge hydrosodée et de l’hypertension artérielle en hémodialyse. Néphrologie & Thérapeutique 9:6, pages 408-415.
Crossref
Crossref
Toshihiko Ishimitsu, Satoshi Ohta, Eri Ohno, Toshiaki Takahashi, Atsushi Numabe, Atsushi Okamura, Shuichi Ohba, Akiko Hashimoto & Hiroaki Matsuoka. (2013) Long-Term Antihypertensive Effects of Aliskiren, a Direct Renin Inhibitor, in Chronic Hemodialysis Patients. Therapeutic Apheresis and Dialysis, pages n/a-n/a.
Crossref
Crossref
L. Darryl Quarles. (2013) Reducing cardiovascular mortality in chronic kidney disease: something borrowed, something new. Journal of Clinical Investigation.
Crossref
Crossref